Company / Operating Cash Flow
Day One Biopharmaceuticals, Inc. Operating Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$103.8M
FY2025
5-year range
-$146.9M / -$48.5M
FY2021-FY2025
Trend
-32.8%
vs FY2024
Sector context
#121 of 214
Health Care
What the data says
At -$104M, Day One Biopharmaceuticals, Inc.'s operating cash flow ranks #121 of 214 in the Health Care sector. Improved from -$147M to -$104M over the past 2 years.
Based on SEC 10-K filings.
-$104M in FY2025.
Improved from -$147M to -$104M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#121 of 214 in Health CareTop 57% of 214This company -$103.8M Sector average $663.6M
▼
-115.6% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 32.8% year-over-year.
- Ranks #121 out of 214 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2019.
- Lowest operating cash flow in the period was in FY2023.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$103.8M | -32.8% |
| FY2024 | -$78.1M | +46.8% |
| FY2023 | -$146.9M | -33.7% |
| FY2022 | -$109.9M | -126.4% |
| FY2021 | -$48.5M | -259.8% |
| FY2020 | -$13.5M | -198.8% |
| FY2019 | -$4.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026